Found 10 matching trials
A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors PHASE1 This is a prospective, single-arm, open-label Phase 1 dose-finding and expa...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. EARLY_PHASE1 This is an open-label, single-arm clinical study designed to evaluate the s...
Show More Location
Hainan Cancer Hospital
Learn More & Join Trial
Clinical Study of CAR-CLD18 T Cells in Patients With Advanced Gastric Adenocarcinoma and Pancreatic Adenocarcinoma NA A single arm, open-label pilot study is designed to determine the safety, t...
Show More Location
Changhai Hospital
Learn More & Join Trial
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial NA The goal of this clinical trial is to assessing the safety and tolerability...
Show More Location
The Affiliated Hospital of Qingdao University
Learn More & Join Trial
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors. PHASE1 An open label, single/multiple dose exploratory clinical study to evaluate ...
Show More Location
Department of GI Oncology, Peking University Cancer Hospital
Learn More & Join Trial
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma PHASE1 A single-arm, open-label early-stage exploratory clinical study to evaluate...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression PHASE1 This is an open label, multi-center, Phase 1 clinical trial to evaluate the...
Show More Location
Changhai Hospital
Learn More & Join Trial
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers PHASE1 The third generation of CAR-T cells that target GPC3, Mesothelin, Claudin18...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Treatments Being Tested
CAR-T cells targeting GPC3, Mesothelin, Claudin18.2, GUCY2C, B7-H3, PSCA, PSMA, MUC1, TGFβ, HER2, Lewis-Y, AXL, or EGFR Learn More & Join Trial
Treating Claudin18.2-positive Advanced Solid Tumors with XKDCT225(Targeting Claudin18.2-CAR-T) PHASE1 A single-center, single-arm, dose-escalation exploratory clinical trial of ...
Show More Location
AnYang Tumor Hospital
Learn More & Join Trial
Exploratory Clinical Study of Claudin18.2-Targeted CAR-DC and CAR-T Therapy in Advanced Colorectal Cancer PHASE1 This is an open-label, single-arm clinical study designed to evaluate the s...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial